Vaccination against canine babesiosis: an overview of field observations

Abstract

Pirodog (ND) is a novel vaccine against canine babesiosis. It is commercially distributed and has been used in France since May 1988. More than 150,000 dogs have now been vaccinated and the results of the immunization have been contradictory. Many things remain to be understood concerning individual susceptibility, the immunosuppressive effect of the disease, and the incidence of concomitant infections.